The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dynamic genomic instability modulation by neoadjuvant therapy in early breast cancer (GEICAM/2006-03_2006-14).
 
Emilio Alba
No Relationships to Disclose
 
Oscar M Rueda
No Relationships to Disclose
 
Ana Lluch
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck (Inst); PharmaMar (Inst); Roche Pharma AG (Inst)
 
Joan Albanell
No Relationships to Disclose
 
Suet-Feung Chin
No Relationships to Disclose
 
Jose Ignacio Chacon
No Relationships to Disclose
 
Lourdes Calvo
No Relationships to Disclose
 
Juan De La Haba
No Relationships to Disclose
 
Begona Bermejo
No Relationships to Disclose
 
Nuria Ribelles
No Relationships to Disclose
 
Pedro Sanchez Rovira
No Relationships to Disclose
 
Arrate Plazaola
No Relationships to Disclose
 
Agusti Barnadas
Consulting or Advisory Role - Novartis; Pfizer
Speakers' Bureau - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Roche
 
Eva Maria Carrasco
Stock and Other Ownership Interests - Lilly
Consulting or Advisory Role - Bristol-Myers Squibb (I); Celgene (I); Novartis (I); Roche Pharma AG (I)
Speakers' Bureau - Bristol-Myers Squibb (I); Celgene (I); Novartis (I); Roche Pharma AG (I)
Research Funding - AstraZeneca Spain (Inst); AstraZeneca Spain (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genomic Health (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - PAM 50 taxane predictor
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I); Celgene (I); Novartis (I); Roche; Roche/Genentech (I)
 
Jesus Herranz
No Relationships to Disclose
 
Massimo Chiesa
No Relationships to Disclose
 
Rosalia Caballero
No Relationships to Disclose
 
Angela Santonja Climent
Travel, Accommodations, Expenses - Celgene
 
Federico Rojo
No Relationships to Disclose
 
Carlos Caldas
Consulting or Advisory Role - AstraZeneca/MedImmune
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); SERVIER (Inst)